Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...

Trump’s nominee for SEC chair has been critical of regulatory burdens for public companies.

The most recent quarter and year in the IPO market maintained trends that have been prevalent since early 2022. Initial ...

Nasdaq president Nelson Griggs discusses the decline of companies going public and when the incentive for initial public ...

After a series of public market collapses, investors and bankers have strict standards for healthcare startups hoping to IPO ...

The crypto exchange whose parent company is backed by Peter Thiel revived its public listing plans shelved in 2022.

Shares of Titan America rose 1.25% in their debut on the New York Stock Exchange, giving the Belgium-based cement producer a ...

You can't currently use an exchange-traded fund (ETF) to gain passive exposure to DeepSeek because it's not a publicly traded ...

I rate PDX as a Strong Buy, anticipating further NAV appreciation and market price alignment following Venture Global's IPO pricing. As you can see from the above chart, Energy sector investments ...

Obesity-drug maker Metsera Inc.’s stock jumped 47% on Friday as the biggest gainer among three initial public offerings bucking a swoon in the equity market ... above its IPO pricing level ...

Shares of medical-device maker Beta Bionics (BBNX) closed at $23.81 for a gain of 40% over its $17-a-share IPO price. The stock first traded at $23.50. In the broad equities market, the Nasdaq ...